- Home
- MOBX vs MDAI Comparison
MOBX vs MDAI Comparison
Compare MOBX & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOBX
- MDAI
- Stock Information
- Founded
- MOBX 2020
- MDAI 2013
- Country
- MOBX United States
- MDAI United States
- Employees
- MOBX N/A
- MDAI N/A
- Industry
- MOBX
- MDAI Medical/Dental Instruments
- Sector
- MOBX
- MDAI Health Care
- Exchange
- MOBX Nasdaq
- MDAI Nasdaq
- Market Cap
- MOBX 57.1M
- MDAI 51.9M
- IPO Year
- MOBX N/A
- MDAI N/A
- Fundamental
- Price
- MOBX $0.94
- MDAI $2.23
- Analyst Decision
- MOBX
- MDAI Strong Buy
- Analyst Count
- MOBX 0
- MDAI 1
- Target Price
- MOBX N/A
- MDAI $3.50
- AVG Volume (30 Days)
- MOBX 1.4M
- MDAI 447.8K
- Earning Date
- MOBX 08-13-2025
- MDAI 11-05-2025
- Dividend Yield
- MOBX N/A
- MDAI N/A
- EPS Growth
- MOBX N/A
- MDAI N/A
- EPS
- MOBX N/A
- MDAI N/A
- Revenue
- MOBX $10,984,000.00
- MDAI $27,549,000.00
- Revenue This Year
- MOBX N/A
- MDAI N/A
- Revenue Next Year
- MOBX N/A
- MDAI $60.05
- P/E Ratio
- MOBX N/A
- MDAI N/A
- Revenue Growth
- MOBX 180.13
- MDAI 22.27
- 52 Week Low
- MOBX $0.55
- MDAI $0.96
- 52 Week High
- MOBX $2.47
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- MOBX 52.40
- MDAI 52.94
- Support Level
- MOBX $0.79
- MDAI $2.05
- Resistance Level
- MOBX $0.88
- MDAI $2.49
- Average True Range (ATR)
- MOBX 0.09
- MDAI 0.15
- MACD
- MOBX -0.00
- MDAI 0.02
- Stochastic Oscillator
- MOBX 48.61
- MDAI 50.00
About MOBX Mobix Labs Inc.
Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.